Arjo AB Earnings Estimate
Arjo AB Earnings per Share Projection vs Actual
About Arjo AB Earnings Estimate
The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Arjo AB earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Arjo AB estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Arjo AB fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.Arjo AB develops and sells medical devices and solutions for patients with reduced mobility and age-related health challenges in North America, Western Europe, and internationally. The company was founded in 1957 and is headquartered in Malm, Sweden. Arjo Ab operates under Medical Distribution classification in the United States and is traded on OTC Exchange. It employs 6500 people.
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Other Information on Investing in Arjo Pink Sheet
Arjo AB financial ratios help investors to determine whether Arjo Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Arjo with respect to the benefits of owning Arjo AB security.